<http://webisa.webdatacommons.org/403977899>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<sec.gov> .
<http://webisa.webdatacommons.org/403977899>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/403977899>	<http://www.w3.org/ns/prov#value>	"As greater numbers of patients use a drug following its approval, side effects and other problems may be observed after approval that were not seen or anticipated during pre-approval" .
<http://webisa.webdatacommons.org/prov/447723289>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/403977899> .
<http://webisa.webdatacommons.org/prov/341675080>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/403977899> .